Chlorhexidine Versus Betadine in Preventing Colonization of Femoral Nerve Catheters After Total Joint Arthroplasty (TJA)

Sponsor
Northwell Health (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00896402
Collaborator
(none)
0
2
2
11
0
0

Study Details

Study Description

Brief Summary

Continuous femoral nerve block (CFNB) techniques continue to be increasingly used in the management of postoperative pain after total knee arthroplasty. Although the risk of full blown infection with CFNB has been poorly defined, the rate of catheter colonization after antisepsis with povidone-iodine has been demonstrated to be high (Cuivillion et al. showed the rate of colonization to be 57% after 48 hours). Recently, several anecdotal case reports have demonstrated severe infectious complications including psoas abscess and necrotizing fasciitis associated with continuous nerve block techniques. As the use of CFNB techniques increase in popularity, infectious complications will undoubtedly become more common.

The American Society of Regional Anesthesia and Pain Medicine recommends the routine use of antiseptic solutions with an alcohol base for skin disinfection before peripheral regional techniques due to their penetration of the stratum corneum and their rapid and prolonged effect. Chlorhexidine(chloraprep) has been proven to be better than povidone iodine solution for skin preparation before epidural catheter and intravascular device insertion (Kinirons et al., Ostrander et al., Mimoz et al.,). The goal of this prospective trial therefore is to determine if an alcoholic solution of 0.5% chlorhexidine is more effective than an aqueous solution of 10% povidone-iodine in reducing catheter colonization and reducing skin flora associated with short term ( 48 hours) postoperative continuous femoral nerve catheter placement. The investigators will also compare the ability of chloraprep and betadine disinfection at the time of catheter placement to prevent bacterial contamination of the continuous femoral catheter.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

After antisepsis four different cultures will be analyzed:
  1. The femoral nerve catheter will be removed after 48 hours and a culture of the distal tip of the femoral nerve catheter will be performed between the 2 arms.

  2. immediately before skin antisepsis, a culture of the the skin will be performed to identify baseline skin flora.

  3. immediately after antisepsis with both betadine and chlorhexidine, a culture of the skin will be performed to assess antiseptic efficacy.

  4. just prior to removal of the femoral nerve catheter, a culture of the skin/catheter interface will be performed between the 2 arms.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Chlorhexidine vs. Betadine in Preventing Colonization of Continuous Femoral Catheters After Total Joint Arthroplasty
Study Start Date :
Jul 1, 2014
Actual Primary Completion Date :
Jan 1, 2015
Actual Study Completion Date :
Jun 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Chlorhexidine

skin antisepsis with chlorhexidine

Drug: Skin antisepsis with chlorhexidine
Chlorhexidine swabs will be used to antiseptically clean the skin, then cultures of the skin and femoral nerve block catheters will be analyzed via standard microbiological techniques
Other Names:
  • Chlora-prep: 2% w/v chlorhexidine and 70% v/v isopropyl alcohol
  • Active Comparator: Povidone-iodine

    skin antisepsis with povidone-iodine

    Drug: povidone-iodine
    Povidone-iodine swabs will be used to antiseptically clean the skin; then cultures of the skin and femoral nerve catheters will be performed by standard microbiologic techniques
    Other Names:
  • Povidone-Iodine, USP 10% topical solution
  • Outcome Measures

    Primary Outcome Measures

    1. Presence or absence of bacterial colonization of the distal femoral catheter tip 48 hours after antiseptic application [July 2013]

    Secondary Outcome Measures

    1. Incidences of bacterial colonization of skin before/after skin antisepsis and skin/catheter interface [July 2013]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • ASA 1-3,

    • Undergoing primary total knee arthroplasty.

    Exclusion Criteria:
    • Hypersensitivity/allergy to antiseptics,

    • Recent opioid/alcohol abuse,

    • Presence of contraindications to regional anesthesia,

    • Coagulation disorder,

    • Diabetic/femoral neuropathy,

    • Prior surgery to inguinal area,

    • Patient refusal.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Syosset Hospital Syosset New York United States 11791
    2 Franklin Hospital Valley Stream New York United States 11580

    Sponsors and Collaborators

    • Northwell Health

    Investigators

    • Principal Investigator: Joseph Marino, M.D., Franklin Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Joseph Marino M.D., Chief of Anesthesiology, Northwell Health
    ClinicalTrials.gov Identifier:
    NCT00896402
    Other Study ID Numbers:
    • 1989mdmd
    First Posted:
    May 11, 2009
    Last Update Posted:
    Aug 27, 2015
    Last Verified:
    Aug 1, 2015
    Keywords provided by Joseph Marino M.D., Chief of Anesthesiology, Northwell Health
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 27, 2015